林业发展局核准美国首次对牛发烧虫进行治疗,仅对未哺乳的牛进行治疗。 FDA approves first treatment for cattle fever ticks in U.S., for non-lactating cattle only.

美国食品和药物管理局已有条件批准Exzolt Cattle-CA1,一种局部的fluralaner溶液,用于两个月以上的肉牛和替代乳牛犊治疗和预防新世界螺丝虫和控制牛热. The FDA has conditionally approved Exzolt Cattle-CA1, a topical fluralaner solution, for beef cattle and replacement dairy heifers over two months old to treat and prevent New World screwworm and control cattle fever ticks. 这是美国首例经林业发展局批准的牛发烧虫治疗,屠宰期为98天,仅用于非哺乳牲畜。 This is the first FDA-approved treatment for cattle fever ticks in the U.S., with a 98-day slaughter withdrawal period and use restricted to non-lactating cattle. 这种药物以处方方式提供,作为单一条条使用,是更广泛的寄生虫管理战略的一部分。 The drug, available by prescription, is applied as a single strip and is part of a broader parasite management strategy. 根据PZAD方案给予的批准,允许最多5年的额外数据支持全面批准。 The approval, granted under the PZAD program, allows up to five years for additional data to support full approval.